WO1995005075A1 - Cryopreservation of porcine embryos - Google Patents
Cryopreservation of porcine embryos Download PDFInfo
- Publication number
- WO1995005075A1 WO1995005075A1 PCT/AU1994/000474 AU9400474W WO9505075A1 WO 1995005075 A1 WO1995005075 A1 WO 1995005075A1 AU 9400474 W AU9400474 W AU 9400474W WO 9505075 A1 WO9505075 A1 WO 9505075A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- embryo
- embryos
- lipid
- temperature
- droplets
- Prior art date
Links
- 210000002257 embryonic structure Anatomy 0.000 title claims abstract description 168
- 238000005138 cryopreservation Methods 0.000 title claims description 12
- 150000002632 lipids Chemical class 0.000 claims abstract description 99
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 83
- 238000000034 method Methods 0.000 claims abstract description 47
- 238000000338 in vitro Methods 0.000 claims abstract description 18
- 230000002829 reductive effect Effects 0.000 claims abstract description 12
- 230000009467 reduction Effects 0.000 claims abstract description 8
- 238000012258 culturing Methods 0.000 claims abstract 3
- 241001465754 Metazoa Species 0.000 claims description 13
- 238000010257 thawing Methods 0.000 claims description 9
- 239000003112 inhibitor Substances 0.000 claims description 4
- 230000003436 cytoskeletal effect Effects 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 3
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 claims description 2
- NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 claims description 2
- 229960005052 demecolcine Drugs 0.000 claims description 2
- 230000002459 sustained effect Effects 0.000 claims description 2
- 238000007710 freezing Methods 0.000 abstract description 25
- 230000008014 freezing Effects 0.000 abstract description 25
- 230000004083 survival effect Effects 0.000 abstract description 19
- 238000005119 centrifugation Methods 0.000 abstract description 7
- 210000004027 cell Anatomy 0.000 description 69
- 210000002459 blastocyst Anatomy 0.000 description 37
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 239000002577 cryoprotective agent Substances 0.000 description 17
- 238000011161 development Methods 0.000 description 16
- 230000018109 developmental process Effects 0.000 description 16
- 210000000805 cytoplasm Anatomy 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 210000004340 zona pellucida Anatomy 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241000255969 Pieris brassicae Species 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 230000012447 hatching Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000010583 slow cooling Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- GBOGMAARMMDZGR-UHFFFAOYSA-N UNPD149280 Natural products N1C(=O)C23OC(=O)C=CC(O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 GBOGMAARMMDZGR-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- GBOGMAARMMDZGR-JREHFAHYSA-N cytochalasin B Natural products C[C@H]1CCC[C@@H](O)C=CC(=O)O[C@@]23[C@H](C=CC1)[C@H](O)C(=C)[C@@H](C)[C@@H]2[C@H](Cc4ccccc4)NC3=O GBOGMAARMMDZGR-JREHFAHYSA-N 0.000 description 4
- GBOGMAARMMDZGR-TYHYBEHESA-N cytochalasin B Chemical compound C([C@H]1[C@@H]2[C@@H](C([C@@H](O)[C@@H]3/C=C/C[C@H](C)CCC[C@@H](O)/C=C/C(=O)O[C@@]23C(=O)N1)=C)C)C1=CC=CC=C1 GBOGMAARMMDZGR-TYHYBEHESA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 244000144980 herd Species 0.000 description 3
- 239000012678 infectious agent Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 231100000518 lethal Toxicity 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 239000010902 straw Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- VJGGHXVGBSZVMZ-QIZQQNKQSA-N Cloprostenol Chemical compound C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(Cl)=C1 VJGGHXVGBSZVMZ-QIZQQNKQSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229960004409 cloprostenol Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000779 depleting effect Effects 0.000 description 2
- 230000013020 embryo development Effects 0.000 description 2
- 210000002308 embryonic cell Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000472 morula Anatomy 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000004017 vitrification Methods 0.000 description 2
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 101100207042 Caenorhabditis elegans unc-94 gene Proteins 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- NAIODHJWOHMDJX-UHFFFAOYSA-N Cytochalasin C Natural products N1C(=O)C23C(OC(C)=O)C=CC(C)(O)C(=O)C(C)CC=CC2C(O)C(C)=C(C)C3C1CC1=CC=CC=C1 NAIODHJWOHMDJX-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000036830 Normal foetus Diseases 0.000 description 1
- 239000004218 Orcein Substances 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004952 blastocoel Anatomy 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229940034629 chorulon Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- NAIODHJWOHMDJX-NGFXLRBHSA-N cytochalasin c Chemical compound C1([C@@H]2C(C)=C(C)[C@@H](O)[C@@H]3\C=C/C[C@@H](C([C@](C)(O)\C=C/[C@@H](OC(C)=O)[C@]32C(=O)N1)=O)C)CC1=CC=CC=C1 NAIODHJWOHMDJX-NGFXLRBHSA-N 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- LEOJDCQCOZOLTQ-UHFFFAOYSA-N dibutylcarbamothioyl n,n-dibutylcarbamodithioate Chemical compound CCCCN(CCCC)C(=S)SC(=S)N(CCCC)CCCC LEOJDCQCOZOLTQ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008143 early embryonic development Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 229940032383 estrumate Drugs 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009399 inbreeding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 235000019248 orcein Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- -1 physical damage Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 150000003169 prostaglandin F2α derivatives Chemical class 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- IFEJLMHZNQJGQU-KXXGZHCCSA-M sodium;(z)-7-[(1r,2r,3r,5s)-2-[(e,3r)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate Chemical compound [Na+].C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC([O-])=O)OC1=CC=CC(Cl)=C1 IFEJLMHZNQJGQU-KXXGZHCCSA-M 0.000 description 1
- 229940099373 sudan iii Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
Definitions
- This invention relates to the cryopreservation of porcine embryos.
- cryoprotectants have been used in conjunction with embryos for several species to minimize the impact of ice crystal formation.
- Two general types of cryoprotectants have been used, permeating substances and non permeating substances.
- Permeating cryoprotectants enter cells and include substances, such a DMSO, or glycerol and act to effectively lower the freezing point These types of cryoprotectants are used to replace intracellular water reducing the likelihood of lethal intracellular ice crystal formation.
- Non-permeating cryoprotectants do not enter the cell. The presence of cryoprotectant outside of a cell can cause the cells to dehydrate, removing intracellular water preventing the formation of large ice crystals within the cell, which would otherwise be lethal to cells.
- membranes that form part of the cellular structure; either as the external membrane that envelope cells to ensure integrity of the cells or internal membrane structures such as those forming the endoplasmic reticulum.
- These membranes comprise a bilayer of phospholipid molecules with other structural components, including protein components embedded within the bilayer.
- the phospholipids usually exist in a fluid state, the fluid state being essential for the proper functioning of the membrane.
- Porcine embryos develop from a single cell (fertilised egg), which divides during the early stages of cell development into a ball of cells without ever increasing its diameter. From the single cell to the blastocyst stage the embryo is covered by a protective layer known as a zona pellucida. The ball of cells in the early stages (from about the 16 cell stage) is referred to as a morula.
- the protective layer is thought to protect the embryo against a variety of agents, including physical damage, and infectious agents, such as viruses, from penetrating into the cell mass of the embryo.
- the porcine embryo develops from the morula to the blastocyst stage on day 4 to 5.
- the blastocyst consists of a single peripheral layer of cells, the trophectoderm or trophoblast, and a group of cells inside the blastocoel cavity termed the inner cell mass cells from which the foetus develops.
- the blastocyst begins to increase its mass, and this stage is known as an expanded blastocyst
- the expanded blastocyst is still enveloped by the zona pellucida.
- the zona pellucida thins as a result of enzymic digestion at about day 6 to 7 and the blastocyst "hatches" out from the zona pellucida.
- Once fully hatched the blastocyst can become implanted and develop further, and at this stage is referred to as a hatched blastocyst.
- the hatching and fully hatched blastocyst is far more susceptible to physical damage and to infection.
- the term peri- hatching or peri-hatched has been coined to refer to embryos that are at any stage of development between and including expanded to fully hatched blastocysts.
- Hayashi et al. (Vet Rec, 125; 43 (1989)) succeeded in obtaining 5 piglets from 11 expanded blastocysts which had been briefly frozen at -35°C with 1.5 M glycerol.
- a live piglet was also produced by transferring 8 Meishan hatched blastocysts (day-7) frozen with 1.4M (10%) glycerol in PBS (Phosphate Buffered Saline) supplemented with 50% FCS and 10% egg yolk by slow cooling and seeding at -7°C with silver iodide (Fujino et al, Cryobiology 30; 299 (1993)). These embryos were transferred to a day-5 recipient with 4 unfrozen Large White hatched blastocysts to assist in the maintenance of pregnancy.
- PBS Phosphate Buffered Saline
- Blastocysts at peri-hatching stages must be chosen. They can be developed from earlier stages using in vitro culture with conventional embryo culture media such as Whittingham's M-16 (J. Reprod. Fert 14(suppl.)7 (1971)). Whitten's (Adv. Biosci. 6; 129 (1971)) or KRB (Davis and Day J. Anim. Sci. 46; 1043 (1978)). Addition of BSA to these media appears to be crucial to confer freezability (Nagashima et al Theriogenology 37; 839 ( 1992)).
- step-wise dilution of the cryoprotectant using step-down sucrose from 0.3 - 0.5M to 0 M appears to protect the embryonic cells from osmotic shock.
- porcine embryos are more susceptible to damage, following freezing and thawing, than other embryos.
- Early stage porcine embryos have a large number of lipid droplets present in the cytoplasm of the cells. These lipid droplets can be stained by Sudan III (a lipid specific stain) and by Nile blue sulphate (a stain specific for neutral lipids). As the embryo develops towards the perihatching stage the size of the lipid droplets decreases, as does the total lipid content It is thought that the lipid droplets act as an energy store for use by the developing embryo.
- the postulated effect of the lipid droplet on the freezability of embryos has been suggested to be either due to an effect that lipid droplets may have on the membrane of the embryo, or alternatively by some physical means, perhaps in preventing the cryoprotectant from penetrating into the embryo, or acting as nuclei for ice crystal formation. Which, if any, of these explanations is correct is however not clear, and before the present invention it was not clear that level of lipid was responsible for the poor survival of embryos after freezing.
- the temperature below which porcine embryos at a stage earlier than peri-hatching do not survive is 15°C. This is also approximately the temperature at which lipid phase separations occur in mammalian cells. Lipid phase separations occur in plasma membranes, internal membranes and also the lipid droplets. Structural changes in lipid droplets also occur around this temperature - they coalesce and form larger droplets. Both changes may cause irreversible damage to the embryo at this stage. It has been further suggested that the high lipid content leads to uneven intracellular ice formation which may also be lethal (Niemann et al Theriogenology 1991 35; 109). SUMMARY OF THE INVENTION
- the survival rate of porcine embryos to cooling and/or freezing can be greatly enhanced by reducing the level of lipid derived from lipid droplets in cells of the embryo.
- the invention therefore could in a broad form be said to reside in a method of cryopreserving a porcine embryo comprising the step of reducing the level of lipid derived from lipid droplets in cells of the embryo, followed by the step of reducing the temperature of the embryo to a storage temperature suitable for storage of the embryo whilst the reduced level of lipid droplets is maintained, the level to which lipid is reduced such that significant damage is not sustained by said embryo when the step of reducing the temperature is performed.
- lipid level may be a parameter that might be varied to best suit the technical means of reducing d e lipid level within cells of the embryo. It would seem however that removal of substantially all of the visible lipid as is possible by any appropriate technical means is desirable.
- the invention could be said to reside in a method of cryopreservation of a porcine embryo, comprising the steps of removing substantially all visible lipid derived from droplets in cells of the embryo and the step of reducing the temperature of the embryo to a temperature suitable for the storage of the embryo.
- the present invention has particular benefit in that it permits cryopreservation of porcine embryos at a stage of development earlier than the perihatching stage. It is to be understood that the temperature at which embryos are to be stored is most desirably that of liquid nitrogen. Alternatively where liquid nitrogen facilities are not available then the temperature attainable by any freezer that might be suitable for the purpose.
- the lipid derived from lipid droplets might conveniently be removed from cells by centrifuging the embryo so as to polarize the lipid in the perivitelline space, between the cells of the embryo and the zona pellucida.
- the lipid may be physically removed from the embryo. This physical removal can be achieved by piercing the zona pellucida of die embryo with a micropipette, contacting the lipid with the micropipette and applying suction to the lipid to remove lipid d rough the micropipette.
- the micromanipulation is done with the assistance of a micromanipulator and a microscope.
- the embryo is preferably treated with a substance such as Cytochalasin C or Demecolcine (which are termed cytoskeletal inhibitors) which relax the cytoskeletal elements to thereby minimise damage caused by piercing the cells.
- a substance such as Cytochalasin C or Demecolcine (which are termed cytoskeletal inhibitors) which relax the cytoskeletal elements to thereby minimise damage caused by piercing the cells.
- the lipid droplets may be removed at the single cells stage of the embryo. This facilitates the removal of the lipid from the cytoplasm. It is found mat cells still survive the physical removal of lipid droplets and can be frozen successfully immediately after such treatment
- the cells of the embryo may also be cultured after removal of lipid before temperature is reduced to the storage temperature. Thus cells may be cultured for 14 to 18 hours before being cooled. Where lipid has been removed from single cells, such embryos are usually at the 2 or 4 cell stage. This extra treaunent is suggested to further enhance the survival rate of embryos. The reasons for this enhanced survival may be that the embryo has had time to recover from the trauma of lipid removal. Additionally further lipid removal may be achieved, because the lipid remaining after removal is further depleted because of the energy demand of the developing embryo.
- microsurgical techniques may and can be destructive to embryonic cells. Such techniques can also damage the zona pellucida, a membranous structure protecting embryos from infection by pathogens. Accordingly viability of frozen embryos so treated is likely to be lower than might be desirable.
- the lipid droplets are polarised away from the cells of the embryo and the embryo is frozen rapidly so that the lipid droplets are not able to redistribute back into the cells to a significant extent before freezing.
- a convenient method for polarising the lipid within the embryo is by centrifugation at a suitable speed, so that the lipid droplets are polarised to the peri-vitelline space, and the temperature is reduced at a rate sufficient to pre-empt the redistribution of lipid back into the cytoplasm of the cells.
- this method of cryopreservation may be part of a broader embryo transfer or breeding program and that the invention also resides in an embryo that has been cryopreserved by any of the methods outlined above. It is to be understood that the invention also encompasses animals produced from embryos that have been so cryopreserved.
- An alternative method for depleting lipids from the embryos may be to collect embryos from sows at or close to ovulation, and culture such embryos. This approach is suggested as a possible means to increase the rate of lipid depletion, because culture of embryos is less efficient than development within a sow, and consequently more energy depleting. It may be possible to deplete the level of lipid droplets within an embryo by in vitro culture techniques without polarisation.
- cryoprotectants Any one of a number of cryoprotectants may be used and the regime and rate at which the temperature is reduced can also be optimised.
- the invention could be said to reside in an embryo which is cryopreserved using the method of cryopreservation of this invention.
- the invention could be said to reside in a method of implantation of an embryo, comprising the step of cryopreserving a porcine embryo as described or defined in this specification, thawing the embryo and implanting the embryo into a recipient.
- the invention is also to be understood to include the method of producing an animal using cryopreserved embryos of this invention, which embryos are then thawed and implanted into recipients and allowed to gestate to give rise to said animal.
- the invention is also to be understood to encompass an animal produced by such method.
- delipation is used, wherein the term delipidization has been used elsewhere the two terms are to be understood to have the same meaning.
- delipation is to be understood not to mean total removal of lipid droplets within the cytoplasm of the embryos but rather to mean a reduction of the lipid, where the majority of lipid droplets are no longer apparent within the cytoplasm of embyronic cells.
- Porcine 1 cell stage embryos treated with 7.5 ⁇ g/ ⁇ ml cytochalashin B were centrifuged to polarize the lipid droplets in the cytoplasm. The resultant lipid layer was then removed by micromanipulation using a bevelled micropipette. Sham operated embryos were treated with cytochalasin B and centrifuged but not delipated. The delipated embryos together with the sham operated and intact controls were then exposed to 4°C for 1 hr in PBS+10%FCS either within 2 h or after a 14 to 18h period of culture in Whitten's medium + 1.5% BSA. Both groups of embryos and the controls were subjected to in vitro culture to compare their survival. Embryos wre deemed to have survived if they cleaved following thawing
- Control 11 0 cooled at 2-4 cell (0%) As shown in Table 1, most of the delipated embryos cleaved after cooling with development of the morula-blastocyst stage, whereas all of the control embryos lysed within 24 hours. The sham operated embryos appeared more tolerant to cooling but none cleaved more than once. In vitro culture for 14 to 18 hours of delipated embryos enhances survival.
- a total of 45 pregnant crossbred gilts (Large White x Landrace) were aborted by intramuscular (i.m.) injection of 1 mg of the prostaglandin F2 ⁇ analogue cloprostenol (Estrumate; Pitman-Moore, New South Wales, Australia) between 24 and 40 days after mating, followed by a second injection of 0.5mg cloprostenol 24 h later.
- 1000 IU of eCG Pregnecol; Heriot AgVet, Vic, Austraha
- Ovulation was induced by i.m. injection of 500 IU hCG (Chorulon; Intervet, New South Wales, Australia) administered approximately 72 h after eCG.
- Embryos were centrifuged in modified PBS (PB1) (Quinn et al J Reprod. Fertil 1982;
- lipid droplets containing 10% foetal calf serum (FCS) and 7.5 ⁇ g/ml cytochalasin B (Sigma Chemical Co., St Louis, MO) in 1.5 ml micro-centrifuge tubes (Treff Lab, Switzerland) at 12000 xg for 8 min at room temperature in order to polarize the lipid droplets in the cytoplasm.
- FCS foetal calf serum
- cytochalasin B Sigma Chemical Co., St Louis, MO
- the resulting lipid layer was then removed as much as possible (fully delipated) or approximately half was removed (partially delipated),by micromanipulation using a bevelled suction pipette (30 ⁇ m in diameter) attached to Narishige micromanipulators (MO- 1081 Tokyo, Japan) under a Nikon inverted microscope (TMD1 Tokyo, Japan).
- Embryos were held in the same medium for micromanipulation as for centrifugation. Sham-operated embryos were treated with cytochalasin B and centrifuged, but were not penetrated with the suction pipette or delipated.
- Embryos were chilled within 2 h after lipid removal or sham operation or were maintained in culture for 14-18 h and then chilled. Embryos were cultured in 50- ⁇ l droplets of Whitten's medium (Whitten Adv Biosci 1971; 6:129-141) supplemented with 15mg ml BSA (fraction V; Pentex, Miles IL) under paraffin oil in a plastic petri dish held under an atmosphere of 5% CO2, 5% O2, and 90% N2 in humidified air at 38.6°C.
- Whitten's medium Whitten Adv Biosci 1971; 6:129-141
- BSA fraction V
- Pentex Pentex, Miles IL
- Control 1-cell 19 0 (0) 0 (0)
- Sham-operated 1-cell 19 1 (5.3)* 0 (0)
- Experiment 3 The ability of delipated embryos to develop in vitro.
- the developmental abiUty in vitro, without chilUng, of fuUy and partiaUy deUpated embryos was compared with that of intact (control) zygotes.
- AU embryos were cultured from the 1-ceU stage for 144 h.
- Table 4 represents the comparison between the development of fuUy and partiaUy delipated embryos and that of control zygotes after culture for 144 h. No significant difference was seen in development between partially and fully deUpated embryos. Moreover, the developmental abiUty of the deUpated embryos appeared to be comparable to that of the control zygotes, except that fewer of the partiaUy deUpated embryos developed to the blastocyst stage (25% vs 57%; p ⁇ 0.05; Table 3). The deUpated embryos cleaved and developed at almost the same rate as the controls. The mean ceU numbers of the deUpated embryos tended to be lower than those for control embryos, but this difference was not significant. CeU numbers in blastocysts derived from fully delipated embryos ranged from 16 to 68; this was comparable with the range for the control blastocysts of 23 to 75.
- FIG. 1. is a comparison of the in vitro development of porcine embryos from which Upid was partiaUy and fully removed (deUpated). Note that polarized Upid droplets left in the partially deUpated embryo (a-d) have redistributed throughout the cytoplasm during culture and the blastomeres of the partiaUy delipated embryos are darker in color than those of the fuUy deUpated embryos (e-h). Photographs were taken immediately after lipd removal (a and e) and at 48 h (b and f), 72 h (c and g) and 120 h (d and h) in culture. Magnification is x200.
- the cytoplasm of partiaUy deUpated embryos was darker in color than that of fuUy deUpated embryos throughout all stages of their development in vitro, indicating that the remaining lipid droplets had redistributed throughout the cytoplasm.
- Control 30 26 25 24 17 34.0 ⁇ 18.38 (86.6)3 (83.3)3 (80.0)3 (56.6)b
- This example of the invention is proposed to comprise three steps, including centrifuging embryos to polarise cytoplasmic Upid, equiUbrating the centrifuged embryos with cryoprotectant and freeze thawing embryos.
- the embryos can be centrifuged at 1-cell to blastocyst stage approximately 12800 x g for 10 to 15 min to polarize cytoplasmic Upid.
- Embryos can be centrifuged with or without cytoskeleton inhibitor (for example 5-10 ⁇ g/ml cytochalasin B, D). After centrifugation the Upid can visuaUsed microscopically as polarised in the peri vitelline space away from the blastinere and inside the zona peUucida.
- cryoprotectant After centrifugation the embryos are equUibrated with cryoprotectant for 1 to 20 min.
- cryprotectants that might be used include, 1-7 M DMSO, glycerol, ethylene glycol, propandiol with or without sucrose, toleharose or other sugars that are commonly used.
- cryoprotectant 1-7 M DMSO, glycerol, ethylene glycol, propandiol with or without sucrose, toleharose or other sugars that are commonly used.
- embryos can be equUibrated with cryoprotectant during the centrifugation.
- the embryos equUibrated with cryoprotectant are loaded into a 0.25ml plastic straw with the freezing solution and cooled directly to -30 to -150°C, foUowed by plunging into Uquid nitrogen.
- Embryos are thawed in a water bath at 10 to 37°C. Cryoprotectant is removed from embryos by stepwise dilution followed by thorough washing with culture medium.
- Embryos at the 2 to 4 ceU stage were deUpated, by use of a micropipette after polarizing the Upid, as described earUer.
- Delipated embryos were cultured for approximately 16 h and 33 were transferred each to two recipients both of whom tested pregnant at day 40 by ultrasound. Both pigs farrowed and produced normal sized litters of 8 and 10 piglets respectively.
- Table 5 shows the results for each of the recipients separately and together. TABLE 5. DeUpated porcine embryos are able to develop to term
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Porcine embryos are cryopreserved using a method for reducing the level of lipid within cells of the embryo followed by freezing the embryo. Reduction of the level of lipid can be achieved either by polarizing the lipid within the embryo by centrifugation of the embryo, followed by rapid freezing or by microsurgical removal of the polarized lipid. Alternatively the level of lipid may be reduced by culturing the embryo in vitro. The reduction of the level of lipid before freezing results in good survival rates and can be used on zona intact porcine embryos.
Description
CRYOPRESERNAΗON OF PORCINE EMBRYOS
HELD OF THE INVENTION This invention relates to the cryopreservation of porcine embryos.
BACKGROUND OF THE INVENTION
The introduction of new genetic material into an animal breeding facility such as a piggery is an important and continuing activity to minimise the negative impact of inbreeding. Additionally, even in outbred herds, it is advantageous to introduce new commercially beneficial genetic traits, such as disease resistance or superior growth characteristics.
In the past the introduction of new genetic material has involved the introduction of new animals into a herd. The logistics of transporting live animals is commercially unwieldy, and all the more so because of the major concerns that are held about disease transmission. Such concerns about disease have lead to the introduction of barriers by some countries to the importation of live animals.
Presently new genetic stock is normally introduced into pig herds by importing semen with which sows are artificially inseminated. The drawback of introducing genetic material using only semen is that backcrosses over several generations are required to achieve the desired genotype.
An alternative approach that is sometime used involves the hysterectomy of term pregnant females and introduction of those offspring to surrogate sows. This technique minimises the risk of transfer of infectious agents between breeding facilities, however, the technique is very limited because the progeny can only be transported for short distances.
There have been great advances in the cryopreservation and implantation of embryos in species other than pigs over the past 2 decades, particularly with cattle. As a result of these advances, cryopreserved bovine embryos are now used extensively for transport of genetic material. In contrast to semen, embryos are preferable for the conservation or introduction of new genetic material.
The advances in cattle have not been mirrored in some species of animal of which pigs are an example and there are still several problems associated with freezing pig
embryos. These problems are not specific for freezing embryos and are also applicable to oocytes.
One of the major problems of freezing embryos is that damage to cells is occasioned as a result of ice crystal formation. Cryoprotectants have been used in conjunction with embryos for several species to minimize the impact of ice crystal formation. Two general types of cryoprotectants have been used, permeating substances and non permeating substances. Permeating cryoprotectants enter cells and include substances, such a DMSO, or glycerol and act to effectively lower the freezing point These types of cryoprotectants are used to replace intracellular water reducing the likelihood of lethal intracellular ice crystal formation. Non-permeating cryoprotectants do not enter the cell. The presence of cryoprotectant outside of a cell can cause the cells to dehydrate, removing intracellular water preventing the formation of large ice crystals within the cell, which would otherwise be lethal to cells.
Another effect of freezing is on the membranes that form part of the cellular structure; either as the external membrane that envelope cells to ensure integrity of the cells or internal membrane structures such as those forming the endoplasmic reticulum. These membranes comprise a bilayer of phospholipid molecules with other structural components, including protein components embedded within the bilayer. The phospholipids usually exist in a fluid state, the fluid state being essential for the proper functioning of the membrane. If the temperature of the membrane is allowed to drop to somewhere between 15 to 20°C a phase transition occurs where the lipids in the membrane are no longer in a fluid state and leads to a loss of viability (Petit and Edidin, Science 184; 1183 (1974)), and the stage at which this loss of viability happens is highly dependent on its lipid composition (Quinn in Quinn and Cherry (eds) "Structural and dynamic properties of lipids and membranes". Portland Press Ltd., London, UK, 1992 pp29).
A number of different freezing and thawing regimes and techniques have been developed for bovine and other embryos. A review of this general area has been written by H Niemann in Theriogenology (1991) Vol 35 page 109. These types of techniques are not universally applicable to all animals and variations exist even within the same species.
There are essentially three basic approaches that are used to freeze embryos, a) controlled freezing and thawing; where a gradual reduction or increase in temperature is
used b) vitrification; using high concentrations of cryopreservant, and c) Ultrarapid freezing; using very rapid freezing techniques.
The reason for the difficulty in freezing porcine embryos is not at all clear. A brief explanation of the development of the embryo development will assist in understanding the problem.
Porcine embryos (as do other embryos) develop from a single cell (fertilised egg), which divides during the early stages of cell development into a ball of cells without ever increasing its diameter. From the single cell to the blastocyst stage the embryo is covered by a protective layer known as a zona pellucida. The ball of cells in the early stages (from about the 16 cell stage) is referred to as a morula. The protective layer is thought to protect the embryo against a variety of agents, including physical damage, and infectious agents, such as viruses, from penetrating into the cell mass of the embryo.
The porcine embryo develops from the morula to the blastocyst stage on day 4 to 5. The blastocyst consists of a single peripheral layer of cells, the trophectoderm or trophoblast, and a group of cells inside the blastocoel cavity termed the inner cell mass cells from which the foetus develops.
At about day 5 to 6 in the pig (the onset of estrus = day 0) the blastocyst begins to increase its mass, and this stage is known as an expanded blastocyst The expanded blastocyst is still enveloped by the zona pellucida. The zona pellucida thins as a result of enzymic digestion at about day 6 to 7 and the blastocyst "hatches" out from the zona pellucida. Once fully hatched the blastocyst can become implanted and develop further, and at this stage is referred to as a hatched blastocyst. The hatching and fully hatched blastocyst is far more susceptible to physical damage and to infection. The term peri- hatching or peri-hatched has been coined to refer to embryos that are at any stage of development between and including expanded to fully hatched blastocysts.
There have been several reports on the survival of porcine embryos after cooling or freezing. Nagashima et al (Jpn. J Anim. Reprod. 341 123 (1988) assessed embryo survival by in vitro culture following exposure to 6°C for 1 or 16 hours and concluded that embryos at the expanded and hatched blastocyst stage survive cooling compared with early blastocysts or morulae that do not. Blastocysts hatched in vitro were shown to be able to maintain their viability and develop to normal foetus after exposure to 11°C. The freezability of the peri-hatched staged blastocysts was further confirmed by
freezing experiments to -20°C (Nagashima et al Jpn. J Anim Reprod. 35 ; 130 (1989)). Hayashi et al. (Vet Rec, 125; 43 (1989)) succeeded in obtaining 5 piglets from 11 expanded blastocysts which had been briefly frozen at -35°C with 1.5 M glycerol.
The freezability of the peri-hatching stage blastocysts to allow storage in liquid nitrogen has subsequently been demonstrated by three groups. Kashiwazaki et al (Therigenology 35;221 (1991) and Vet Rec 16;256 (1991)) used in vitro hatched blastocysts which had been collected from Large White and cross bred (Meishan x Meishan/Large White Fi) donors and cultured for 18-24 hours in modified KRB (Davis etal J. Anim. Sci. 46; 1043 (1978)) supplemented with 4mg/ml BSA and 10% foetal calf serum (FCS). These embryos were frozen by a conventional slow cooling method in the presence of 1.5M glycerol to -35°C (seeded at -6.8°C) followed by plunging into liquid nitrogen. After thawing in a 35°C water bath, the cryoprotectant was removed by step-wise dilution. Thirty two embryos were transferred to a day-6 recipient and three Large White and one crossbred piglets were born.
A live piglet was also produced by transferring 8 Meishan hatched blastocysts (day-7) frozen with 1.4M (10%) glycerol in PBS (Phosphate Buffered Saline) supplemented with 50% FCS and 10% egg yolk by slow cooling and seeding at -7°C with silver iodide (Fujino et al, Cryobiology 30; 299 (1993)). These embryos were transferred to a day-5 recipient with 4 unfrozen Large White hatched blastocysts to assist in the maintenance of pregnancy.
Kameyama et al. (Proceedings of 78th Annual Meeting of The Japanese Society of Animal Reproduction. Niigata, Japan , 1990, p22 Abstr.) cryopreserved expanded blastocysts collected on day-6 using a freezing solution containing 1.5 M glycerol, 0.05% lecithine and 15% FCS in PBS. The embryos were cooled rapidly from room temperatures to the seeding temperature (-6.8°C) and then cooled slowly to -35°C, followed by plunging into liquid nitrogen. Transfer of the 20 frozen-thawed embryos to a single recipient resulted in the birth of 2 live and 2 stillborn piglets.
In vitro culture of embryos frozen in liquid nitrogen showed that the survival rates were between 17-50% for expanded blastocysts (Hayashi et al Vet Rec 125 ;43 (1989)), Kashiwazaki et al Vet Rec 16; 256 (1991)), Nagashima et al Theriogenology 37;839 (1992), Cameron et al Proceedings of 12th International Pig Veterinary Society. Hague, The Netherlands, 1992 p476 Abstr., Dobrinsky et al Proceedings of the 4th International Conference on Pig Reproduction, Columbia, USA, 1993, p35 Abstr.) and between 38% to 96% for hatching and hatched blastocysts (Fujino et al Cryobiology
30;299 (1993), Hayashi et al Vet Rec 125;43 (1989)), Kashiwazaki et al Vet Rec 16; 256 (1991)), Nagashima et al Theriogenology 37;839 (1992), Cameron et al Proceedings of 12th International Pig Veterinary Society. Hague, The Netherlands , 1992 p476 Abstr., Dobrinsky et al Proceedings of the 4th International Conference on Pig Reproduction, Columbia, USA, 1993, p35 Abstr., French et al Proceedings of The 23rd Annual Conference of Australian Society of Reproductive Biology, Sydney, Australia 1991, pi 19 Abstr.). In contrast, embryos younger than expanded blastocyst stage as well as hatched blastocysts having a diameter larger than 300μm do not survive freezing, indicating that the freezability of porcine blastocysts peaks immediately after hatching and then decreases rapidly.
From these data, it appears that the most appropriate conditions presently known for cryopreservation of porcine embryos are as follows:-
(A) Blastocysts at peri-hatching stages must be chosen. They can be developed from earlier stages using in vitro culture with conventional embryo culture media such as Whittingham's M-16 (J. Reprod. Fert 14(suppl.)7 (1971)). Whitten's (Adv. Biosci. 6; 129 (1971)) or KRB (Davis and Day J. Anim. Sci. 46; 1043 (1978)). Addition of BSA to these media appears to be crucial to confer freezability (Nagashima et al Theriogenology 37; 839 ( 1992)).
(B) As a cryoprotectant 1.5 M of glycerol seems to be effective, though a thorough screening for other cryoprotectants has yet to be carried out.
(C) Conventional slow cooling methods can be used, probably with wide tolerance for cooling rates as slow as l°C min or direct cooling from ambient temperature to seeding temperature (-6 to -7°C), followed by slow cooling at 0.3°C/min to -35 to -38°C and plunging into liquid nitrogen.
(D) After rapid thawing in a water bath at 35-37°C, step-wise dilution of the cryoprotectant using step-down sucrose from 0.3 - 0.5M to 0 M appears to protect the embryonic cells from osmotic shock.
Thus attempts have been made to freeze embryos of pigs at a variety of stages of development however, only embryos at the perihatching stage have been successfully frozen, and the rate of successful pregnancies following storage of embryos has been very low.
It is however highly desirable to have access to frozen embryos that have not yet "hatched" or whose zona pellucida has not thinned, because where hatching or thinning has occurred such blastocysts are far more susceptible to infectious agents or physical damage.
Several possible explanations exist as to why porcine embryos are more susceptible to damage, following freezing and thawing, than other embryos. Early stage porcine embryos have a large number of lipid droplets present in the cytoplasm of the cells. These lipid droplets can be stained by Sudan III (a lipid specific stain) and by Nile blue sulphate (a stain specific for neutral lipids). As the embryo develops towards the perihatching stage the size of the lipid droplets decreases, as does the total lipid content It is thought that the lipid droplets act as an energy store for use by the developing embryo.
It has been postulated that this reduction of lipid content is associated with the freezability of embryos because changes in the number and size of these droplets have been correlated with stages at which the embryos from different species can be successfully frozen. Porcine embryos contain a large number of lipid droplets throughout early embryonic development and have not been successfully frozen before the perihatching stage at which time there is a marked reduction in the amount of lipid contained within these vesicles.
The postulated effect of the lipid droplet on the freezability of embryos has been suggested to be either due to an effect that lipid droplets may have on the membrane of the embryo, or alternatively by some physical means, perhaps in preventing the cryoprotectant from penetrating into the embryo, or acting as nuclei for ice crystal formation. Which, if any, of these explanations is correct is however not clear, and before the present invention it was not clear that level of lipid was responsible for the poor survival of embryos after freezing.
The temperature below which porcine embryos at a stage earlier than peri-hatching do not survive is 15°C. This is also approximately the temperature at which lipid phase separations occur in mammalian cells. Lipid phase separations occur in plasma membranes, internal membranes and also the lipid droplets. Structural changes in lipid droplets also occur around this temperature - they coalesce and form larger droplets. Both changes may cause irreversible damage to the embryo at this stage. It has been further suggested that the high lipid content leads to uneven intracellular ice formation which may also be lethal (Niemann et al Theriogenology 1991 35; 109).
SUMMARY OF THE INVENTION
It has been found according to one aspect of this invention that the survival rate of porcine embryos to cooling and/or freezing can be greatly enhanced by reducing the level of lipid derived from lipid droplets in cells of the embryo.
It is found also that the survival of embryos after freezing can be achieved much earlier than at the peri-hatching stage by reducing the level of lipid derived from lipid droplets in cells of the embryo, and as early as the single cell stage of embryo development.
The invention therefore could in a broad form be said to reside in a method of cryopreserving a porcine embryo comprising the step of reducing the level of lipid derived from lipid droplets in cells of the embryo, followed by the step of reducing the temperature of the embryo to a storage temperature suitable for storage of the embryo whilst the reduced level of lipid droplets is maintained, the level to which lipid is reduced such that significant damage is not sustained by said embryo when the step of reducing the temperature is performed.
The extent to which lipid derived from lipid droplets needs to be removed in order that an improvement in the viability of cryopreserved embryos is obtained is not fully defined. The experiments conducted thus far show that if approximately half of the observable lipid is allowed to remain in cells of the embryo then minimal benefits are obtained. Photomicrographs of embryos, where as much lipid has been removed as is technically possible, indicate clearly that some lipid remains. Therefore benefit is obtained without total removal of lipid derived from the lipid droplets. The cut-off point at which benefits are derived has thus not been quantitatively defined, and from a point of view of practicing the invention lipid level may be a parameter that might be varied to best suit the technical means of reducing d e lipid level within cells of the embryo. It would seem however that removal of substantially all of the visible lipid as is possible by any appropriate technical means is desirable.
In an alternative form, the invention could be said to reside in a method of cryopreservation of a porcine embryo, comprising the steps of removing substantially all visible lipid derived from droplets in cells of the embryo and the step of reducing the temperature of the embryo to a temperature suitable for the storage of the embryo.
The present invention has particular benefit in that it permits cryopreservation of porcine embryos at a stage of development earlier than the perihatching stage.
It is to be understood that the temperature at which embryos are to be stored is most desirably that of liquid nitrogen. Alternatively where liquid nitrogen facilities are not available then the temperature attainable by any freezer that might be suitable for the purpose.
The lipid derived from lipid droplets might conveniently be removed from cells by centrifuging the embryo so as to polarize the lipid in the perivitelline space, between the cells of the embryo and the zona pellucida.
After polarization (or removal of lipids from cells), the lipid may be physically removed from the embryo. This physical removal can be achieved by piercing the zona pellucida of die embryo with a micropipette, contacting the lipid with the micropipette and applying suction to the lipid to remove lipid d rough the micropipette. The micromanipulation is done with the assistance of a micromanipulator and a microscope.
During the physical removal of lipid derived from lipid droplets of the embryo, the embryo is preferably treated with a substance such as Cytochalasin C or Demecolcine (which are termed cytoskeletal inhibitors) which relax the cytoskeletal elements to thereby minimise damage caused by piercing the cells.
The lipid droplets may be removed at the single cells stage of the embryo. This facilitates the removal of the lipid from the cytoplasm. It is found mat cells still survive the physical removal of lipid droplets and can be frozen successfully immediately after such treatment
The cells of the embryo may also be cultured after removal of lipid before temperature is reduced to the storage temperature. Thus cells may be cultured for 14 to 18 hours before being cooled. Where lipid has been removed from single cells, such embryos are usually at the 2 or 4 cell stage. This extra treaunent is suggested to further enhance the survival rate of embryos. The reasons for this enhanced survival may be that the embryo has had time to recover from the trauma of lipid removal. Additionally further lipid removal may be achieved, because the lipid remaining after removal is further depleted because of the energy demand of the developing embryo.
There are drawbacks associated with the physical removal of lipid droplets from embryos. One difficulty is that the described method preferably involves microsurgical techniques, which are complicated and time consuming. Where the technique is to be
used on a large scale the associated equipment labour and time costs are likely to be commercially prohibitive.
A further drawback is that microsurgical techniques may and can be destructive to embryonic cells. Such techniques can also damage the zona pellucida, a membranous structure protecting embryos from infection by pathogens. Accordingly viability of frozen embryos so treated is likely to be lower than might be desirable.
For these reasons a protocol for cryopreserving porcine embryos using a non-invasive method for delipation is desirable.
Earlier experiments by the applicant have shown that polarisation of cytoplasmic lipid in embryos by centrifugation did not confer freezability on embryos. This is because the polarised lipid left in the peri vitelline space is redistributed into the cytoplasm before the embryo freezes using conventional slow cooling methods. However, it is proposed that if the embryos with polarised lipid are frozen rapidly using rapid freezing or vitrification methods for example, there is insufficient time for the lipid to return to the cytoplasm and hence the embryos can be successfully cryopreserved.
In a further form of the present invention the lipid droplets are polarised away from the cells of the embryo and the embryo is frozen rapidly so that the lipid droplets are not able to redistribute back into the cells to a significant extent before freezing.
A convenient method for polarising the lipid within the embryo is by centrifugation at a suitable speed, so that the lipid droplets are polarised to the peri-vitelline space, and the temperature is reduced at a rate sufficient to pre-empt the redistribution of lipid back into the cytoplasm of the cells.
It is to be understood that this method of cryopreservation may be part of a broader embryo transfer or breeding program and that the invention also resides in an embryo that has been cryopreserved by any of the methods outlined above. It is to be understood that the invention also encompasses animals produced from embryos that have been so cryopreserved.
An alternative method for depleting lipids from the embryos may be to collect embryos from sows at or close to ovulation, and culture such embryos. This approach is suggested as a possible means to increase the rate of lipid depletion, because culture of embryos is less efficient than development within a sow, and consequently more energy
depleting. It may be possible to deplete the level of lipid droplets within an embryo by in vitro culture techniques without polarisation.
Any one of a number of cryoprotectants may be used and the regime and rate at which the temperature is reduced can also be optimised.
It is to be understood that whilst it is found highly desirable to use this invention for porcine embryo cryopreservation, it may also be desired to use the present method for the cryopreservation of embryos derived from other species.
In a further aspect the invention could be said to reside in an embryo which is cryopreserved using the method of cryopreservation of this invention.
In another aspect the invention could be said to reside in a method of implantation of an embryo, comprising the step of cryopreserving a porcine embryo as described or defined in this specification, thawing the embryo and implanting the embryo into a recipient.
The invention is also to be understood to include the method of producing an animal using cryopreserved embryos of this invention, which embryos are then thawed and implanted into recipients and allowed to gestate to give rise to said animal. The invention is also to be understood to encompass an animal produced by such method.
EXAMPLES
For a better understanding the invention will now be described with reference to the examples.
Throughout this specification the term delipation is used, wherein the term delipidization has been used elsewhere the two terms are to be understood to have the same meaning. The term delipation is to be understood not to mean total removal of lipid droplets within the cytoplasm of the embryos but rather to mean a reduction of the lipid, where the majority of lipid droplets are no longer apparent within the cytoplasm of embyronic cells.
Many of the techniques used in the examples are ones that are practiced by skilled embryologists. A general reference to typical methods that might be employed may be found in the reference "Embryo Transfer in Large Domestic Mammals" by Murray F.
A., in "Methods in Mammalian Reproduction" edited by J.C. Daniel Jr (Academic Press 1978).
EXAMPLE I
Porcine 1 cell stage embryos treated with 7.5μg/μml cytochalashin B were centrifuged to polarize the lipid droplets in the cytoplasm. The resultant lipid layer was then removed by micromanipulation using a bevelled micropipette. Sham operated embryos were treated with cytochalasin B and centrifuged but not delipated. The delipated embryos together with the sham operated and intact controls were then exposed to 4°C for 1 hr in PBS+10%FCS either within 2 h or after a 14 to 18h period of culture in Whitten's medium + 1.5% BSA. Both groups of embryos and the controls were subjected to in vitro culture to compare their survival. Embryos wre deemed to have survived if they cleaved following thawing
It is known that the majority of damage to cells in pig embryos is at temperatures at between 15 - 20°C, and the survival of embryos at the temperatures described in this example are expected to reflect the survival of embryos when frozen.
TABLE 1. Survival of porcine delipated embryos after cooling to 4ΩQ.
Treatment No. embryos No. survived Most advanced cooled development
Delipated and 22 14 8-cell cooled immediately (63%)
Sham operated 14 1 2-cell cooled immediately (7%)
Control 14 0 cooled immediately (0%)
Delipated and 24 22 Blastocyst cooled at 2-4 cell (92%)
Sham operated 15 4 cleaved once cooled at 2-4 cell (27%)
Control 11 0 cooled at 2-4 cell (0%)
As shown in Table 1, most of the delipated embryos cleaved after cooling with development of the morula-blastocyst stage, whereas all of the control embryos lysed within 24 hours. The sham operated embryos appeared more tolerant to cooling but none cleaved more than once. In vitro culture for 14 to 18 hours of delipated embryos enhances survival.
EXAMPLE 2.
Collection of Embryos
A total of 45 pregnant crossbred gilts (Large White x Landrace) were aborted by intramuscular (i.m.) injection of 1 mg of the prostaglandin F2α analogue cloprostenol (Estrumate; Pitman-Moore, New South Wales, Australia) between 24 and 40 days after mating, followed by a second injection of 0.5mg cloprostenol 24 h later. At the time of the second injection, 1000 IU of eCG (Pregnecol; Heriot AgVet, Vic, Austraha) was administered i.m. Ovulation was induced by i.m. injection of 500 IU hCG (Chorulon; Intervet, New South Wales, Australia) administered approximately 72 h after eCG. On the next afternoon (Day 0), the gilts were mated with fertile Large White boars, and zygotes were surgically collected 49-53 h after the hCG injection (Day 1). Embryos collected from each donor were allocated across all treatments in each experiment.
Removal of Lipid Droplets from Embryos.
Embryos were centrifuged in modified PBS (PB1) (Quinn et al J Reprod. Fertil 1982;
66:161-168) containing 10% foetal calf serum (FCS) and 7.5 μg/ml cytochalasin B (Sigma Chemical Co., St Louis, MO) in 1.5 ml micro-centrifuge tubes (Treff Lab, Switzerland) at 12000 xg for 8 min at room temperature in order to polarize the lipid droplets in the cytoplasm. The resulting lipid layer was then removed as much as possible (fully delipated) or approximately half was removed (partially delipated),by micromanipulation using a bevelled suction pipette (30μm in diameter) attached to Narishige micromanipulators (MO- 1081 Tokyo, Japan) under a Nikon inverted microscope (TMD1 Tokyo, Japan). Embryos were held in the same medium for micromanipulation as for centrifugation. Sham-operated embryos were treated with cytochalasin B and centrifuged, but were not penetrated with the suction pipette or delipated.
After lipid removal or sham operation, the embryos were washed and maintained in PB1 +10% FCS at 37° C until chilling or culture.
Culture and Chilling of the Lipid-Removed Embryos
Embryos were chilled within 2 h after lipid removal or sham operation or were maintained in culture for 14-18 h and then chilled. Embryos were cultured in 50-μl droplets of Whitten's medium (Whitten Adv Biosci 1971; 6:129-141) supplemented with 15mg ml BSA (fraction V; Pentex, Miles IL) under paraffin oil in a plastic petri dish held under an atmosphere of 5% CO2, 5% O2, and 90% N2 in humidified air at 38.6°C.
For chilling, embryos were loaded into 0.25 ml plastic straws with PB1 + 10% FCS; to expose the embryos to 4°C, the straws were submerged in iced water for 1 hr and then rewarmed to 37°C by being laid on a warming tray. The recovered embryos were then cultured in Whitten's medium as described above for assessment of their survival. Embryos that cleaved at least once were assessed as surviving. The 1-cell and 2- to 4- cell delipated embryos were cultured for 144 and 120 h, respectively. Some of the cultured embryos (n=20-45) were fixed and stained by aceto-alcohol and 1% aceto- orcein in order to count cell numbers.
Statistics
Survival rates and developmental rates of embryos were compared using ANOVA. When ANOVA revealed a significant difference between groups, the difference was analysed by X2 test. Student's t- test was used to compare mean cell numbers of embryos.
Experiment 1 Chilling of lipid-removed embryos at the 1 cell or 2- to 4-cell stages Chilling sensitivity of delipated, sham-operated, and intact embryos (control) was investigated. These embryos were chilled at the 1-cell stage or at the 2- to 4- cell stage following culture, and their survival (cleavage and subsequent division) was assessed by culture for 144 h and 120 h, respectively.
A total of 120 zygotes were fully delipated. Ninety four (78.3%) embryos in which the cytoplasm remained intact after micromanipulation were chilled either within 2 h of lipid removal while still at the 1-cell stage or after further development in culture to the 2- to 4-cell stage. Control and sham operated embryos at identical stage of development were chilled concurrently.
As shown in Table 2, more than 60% of the delipated embryos cleaved after chilling with development beyond the 8 cell stage, whereas all of the control embryos had lysed within 24 h. Although overall survival rates of the delipated embryos were almost
equal between those chilled at the 1 cell stage and those chilled at the 2- to 4- cell stage, more embryos developed beyond the 8-cell stage when they were chilled at the 2- 4- cell stage (44.4% vs 18.4%, ρ< 0.01). This included 5 (11.1%) embryos that developed to the blastocyst stage. None of the sham-operated embryos cleaved more than once after chilling at the 1-cell stage or developed beyond the 5-cell stage after chilling at the 2- to 4- cell stage.
TABLE 2. Survival of the lipid-removed (delipated) porcine embryos after chilling to 4°C at the 1-cell and 2- to 4- cell stage.
No. of
No. of embryos
Embryonic No. of Embryos developing to stage at embryos surviving ≥ 8-cell stage
Embryos chilling * Chilled** (%) (%)
Control 1-cell 19 0 (0) 0 (0)
Control 2- to 4- cell 16 0 (0) 0 (0)
Sham-operated 1-cell 19 1 (5.3)* 0 (0)
Sham-operated 2- to 4- cell 18 4 (22.2)at> 0 (0)
Delipated 1 - cell 49 32 (65.3)c 9 (18.4)d
Delipated 2- to 4- cell 45 28 (62.2)c 20 (44.4)d a,b,c Values with different superscript within column differ significantly, a vs c p<0.001; b vs c p<0.005; dp < 0.01
* Embryos delipated at the 1-cell stage were chilled immediately or cultured 14 - 18h before being chilled at -4 cell stage.
** Three experiments were repeated in each group
Experiment 2: Comparison of chilling sensitivity after partial and full lipid removal. The aim of the second experiment was to investigate whether partial removal of lipid could render porcine embryos equally tolerant to chilling without compromising their in vitro developmental ability. Fully and partially delipated embryos were chilled at the 2- to 4- cell stage and their development was examined by culture for 120 h.
As shown in Table 3, the number of partially delipated embryos that survived chilling was similar to the number for fully delipated embryos (77.5% vs 90.4%, no significant difference); however, fewer developed beyond the 8-cell stage (32.5% vs. 73.1%, p<0.001) or to the blastocyst stage (7.5% vs 26.9%, p<0.05).
TABLE 3. Comparison of the in vitro development of the fuUy and partiaUy Upi- removed (deUpated) porcine embryos after chilling
No. of No. of embryos Mean
No. of embryos developing to: (±SE) embryos surviving ≥ 8 - ceU ≥ blastocyst number
Embryos ChiUed (%) stage (%) stage (%) of cells **
FuUy 52* 47 38 14 12.8± 5.28 deUpated (90.4)a (73J)b (26.9)d
PartiaUy 40* 31 13 3 11.9±9.28 deUpated (77.5)a (32.5)c (7.5)e a No significantly different b-c p<0.001; d>e p< 0.05
* Six experiments were repeated in each group.
** Twenty embryos in each group were used to count cells.
Experiment 3 : The ability of delipated embryos to develop in vitro. The developmental abiUty in vitro, without chilUng, of fuUy and partiaUy deUpated embryos was compared with that of intact (control) zygotes. AU embryos were cultured from the 1-ceU stage for 144 h.
Table 4 represents the comparison between the development of fuUy and partiaUy delipated embryos and that of control zygotes after culture for 144 h. No significant difference was seen in development between partially and fully deUpated embryos. Moreover, the developmental abiUty of the deUpated embryos appeared to be comparable to that of the control zygotes, except that fewer of the partiaUy deUpated embryos developed to the blastocyst stage (25% vs 57%; p < 0.05; Table 3). The deUpated embryos cleaved and developed at almost the same rate as the controls. The mean ceU numbers of the deUpated embryos tended to be lower than those for control embryos, but this difference was not significant. CeU numbers in blastocysts derived from fully delipated embryos ranged from 16 to 68; this was comparable with the range for the control blastocysts of 23 to 75.
FIG. 1. is a comparison of the in vitro development of porcine embryos from which Upid was partiaUy and fully removed (deUpated). Note that polarized Upid droplets left in the partially deUpated embryo (a-d) have redistributed throughout the cytoplasm during culture and the blastomeres of the partiaUy delipated embryos are darker in color than those of the fuUy deUpated embryos (e-h). Photographs were taken immediately
after lipd removal (a and e) and at 48 h (b and f), 72 h (c and g) and 120 h (d and h) in culture. Magnification is x200.
As shown in Figure 1, the cytoplasm of partiaUy deUpated embryos was darker in color than that of fuUy deUpated embryos throughout all stages of their development in vitro, indicating that the remaining lipid droplets had redistributed throughout the cytoplasm.
TABLE 4. In vitro developmental abUity of Upid-removed (deUpated) porcine embryos.
Mean No. of No embryos developed to: (±SE)
Embryos Cleaved ≥ 4- Cell ≥ 8-ceU Blastocyst number
Embryos cultured (%) (%) (%) (%) of ceUs**
Control 30 26 25 24 17 34.0 ±18.38 (86.6)3 (83.3)3 (80.0)3 (56.6)b
PartiaUy 36 29 29 26 9 18.5±15.0a deUpated (80.6)3 (80.6)3 (72.2)3 (25.0)c embryos
FuUy 48 45 45 38 19 19.5 ± 14.63 deUpated (93.8)3 (93.8)3 (79.2)3 (39.6)bc embryos
Values with different superscipt within columns differ significantly. b-c (p<0.005).
* Three experiments were repeated in each group
** Twenty five to 45 embryos were used to count cell numbers.
EXAMPLE 3
The methods employed here are simUar to those employed in the previous examples. 158 delipated 2-4 cell embryos were frozen and stored in Uquid nitrogen. These were thawed, cultured for three hours and their morphology assessed at the end of this period Embryos having the same morphology before freezing were judged to be suitable for transfer (normaUy color of the cytoplasm and integrity of the cytoplasmic membrane can be the criteria). 95% of embryos showed Uttle or no evidence of damage and were transferred to 4 recipients (30-40 embryos per recipient). Three of the four recipients were confirmed to be pregnant at 50 days of gestation using ultrasound to detect foetuses. Skeleton, membranes, internal organs and heart movement were visualised.
EXAMPLE 4
This example of the invention is proposed to comprise three steps, including centrifuging embryos to polarise cytoplasmic Upid, equiUbrating the centrifuged embryos with cryoprotectant and freeze thawing embryos.
The embryos can be centrifuged at 1-cell to blastocyst stage approximately 12800 x g for 10 to 15 min to polarize cytoplasmic Upid. Embryos can be centrifuged with or without cytoskeleton inhibitor (for example 5-10μg/ml cytochalasin B, D). After centrifugation the Upid can visuaUsed microscopically as polarised in the peri vitelline space away from the blastinere and inside the zona peUucida.
After centrifugation the embryos are equUibrated with cryoprotectant for 1 to 20 min. Examples of cryprotectants that might be used include, 1-7 M DMSO, glycerol, ethylene glycol, propandiol with or without sucrose, toleharose or other sugars that are commonly used. To minimise the time for Upid to re-enter the cytoplasm, embryos can be equUibrated with cryoprotectant during the centrifugation.
The embryos equUibrated with cryoprotectant are loaded into a 0.25ml plastic straw with the freezing solution and cooled directly to -30 to -150°C, foUowed by plunging into Uquid nitrogen.
Embryos are thawed in a water bath at 10 to 37°C. Cryoprotectant is removed from embryos by stepwise dilution followed by thorough washing with culture medium.
EXAMPLE 5
Embryos at the 2 to 4 ceU stage were deUpated, by use of a micropipette after polarizing the Upid, as described earUer. Delipated embryos were cultured for approximately 16 h and 33 were transferred each to two recipients both of whom tested pregnant at day 40 by ultrasound. Both pigs farrowed and produced normal sized litters of 8 and 10 piglets respectively. Table 5 shows the results for each of the recipients separately and together.
TABLE 5. DeUpated porcine embryos are able to develop to term
* DeUpated 2-4 cell stage/developed to 4 to 8 ceU stage in culture for approximately 16 h.
This finding demonstrates that the removal of Upd from the embryo does not affect its abUity to develop to term.
Claims
1. A method of cryopreserving a porcine embryo comprising the step of reducing the level of Upid derived from Upid droplets in ceUs of the embryo, followed by the step of reducing the temperature of the embryo to a storage temperature suitable for storage of the embryo whUst the reduced level of lipid droplets is maintained, the level to which Upid is reduced such that significant damage is not sustained by said embryo when the step of reducing the temperature is performed.
2. A method of cryopreservation of a porcine embryo, comprising the steps of removing substantially all visible lipid derived from droplets in cells of the embryo and the step of reducing the temperature of the embryo to a storage temperature suitable for storage of the embryo.
3. A method for cryopreservation of a porcine embryo comprising the step of removing substantiaUy all the Upid droplets from the cells of the embryo, followed by the step of reducing the temperature of the embryo to a storage temperature suitable for storage of the embryo, said reduction of temperature being effected without lipid from said lipid droplets being redistributed into the embryo to an extent that significant damage is occasioned to the embryo during the reduction in temperature.
4. The method as in claim 3 wherein the Upid droplets are removed from the cells into a perivitelUne space of the embryo and the temperature is reduced at a rate sufficient to prevent the redistribution of lipid back into the cells of the embryo.
5. The method as in claim 3 wherein step of removing substantiaUy all the lipid droplets is achieved by polarizing the Upid droplets of the embryo, and the method further includes the step of physical removal of the Upid droplets from the embryo.
6. The method as in claim 5 wherein the step of physical removal includes piercing the outer surface of a cell or cells of the embryo with a micropipette, contacting the lipid with the pointed tube and applying suction to the Upid to remove Upid through the micropipette.
7. The method as in claim 6 wherein the ceUs of the embryo are treated with an cytoskeletal inhibitor, to thereby minimise damage caused by piercing the ceUs.
8. The method as in claim 7 wherein the inhibitor is selected from the group comprising cytochalashin and Demecolcine.
9. The method as in claim 8 including the further step of in vitro culturing the embryos after physicaUy removing the Upid droplets before the step of reducing the temperature.
10. The method as in claim 3 wherein the step of removing substantially all the lipid droplets from the ceUs of the embryo is achieved by in vitro culturing of said embryo.
11. The method as in either claim 1, 2 or 3 wherein the temperature is reduced at a stage of perihatching or eariier.
12. The method as in claim 11 wherein the temperature is reduced at a stage eariier than perihatching.
13. The method as in claim 12 wherein the temperature is reduced at the single cell stage.
14. An embryo which is cryopreserved using the method of claim 1.
15. A method of implantation of an embryo, comprising the step of cryopreserving a porcine embryo as in claim 1, thawing the embryo and implanting the embryo into a recipient.
16. A method of producing an animal using cryopreserved embryos of claim 11 , which embryos are then thawed and implanted into recipients and aUowed to gestate to give rise to said animal.
17. An animal produced by a method according to claim 16.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU74532/94A AU7453294A (en) | 1993-08-13 | 1994-08-12 | Cryopreservation of porcine embryos |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM055193 | 1993-08-13 | ||
AUPM0551 | 1993-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995005075A1 true WO1995005075A1 (en) | 1995-02-23 |
Family
ID=3777129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU1994/000474 WO1995005075A1 (en) | 1993-08-13 | 1994-08-12 | Cryopreservation of porcine embryos |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1995005075A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2306503A (en) * | 1995-10-30 | 1997-05-07 | Japanese Research Ass For Anim | A method of directly freezing porcine embryo |
WO2000030441A1 (en) * | 1998-11-24 | 2000-06-02 | Bresagen Limited | Cryopreservation of oocytes and embryos and methods for producing animals involving the same |
WO2001093676A1 (en) * | 2000-06-16 | 2001-12-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Cryopreservation of swine embryos |
EP2331677A1 (en) * | 2008-08-29 | 2011-06-15 | The Curators Of The University Of Missouri | High-throughput and non-invasive method to vitrify porcine embryos |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7399574A (en) * | 1973-11-23 | 1976-04-08 | Augspurger L L | Embryo transplantation |
JPS6335501A (en) * | 1986-07-30 | 1988-02-16 | Snow Brand Milk Prod Co Ltd | Freeze-storage of early embryo of rat |
GB2219923A (en) * | 1988-06-22 | 1989-12-28 | Inst Kriobiologii I Kriomedits | Method for low-temperature preservation of embryos |
JPH02117601A (en) * | 1988-10-27 | 1990-05-02 | Itochu Shiryo Kk | Frozen fertilized ovum of pig and freezing preservation thereof |
-
1994
- 1994-08-12 WO PCT/AU1994/000474 patent/WO1995005075A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7399574A (en) * | 1973-11-23 | 1976-04-08 | Augspurger L L | Embryo transplantation |
JPS6335501A (en) * | 1986-07-30 | 1988-02-16 | Snow Brand Milk Prod Co Ltd | Freeze-storage of early embryo of rat |
GB2219923A (en) * | 1988-06-22 | 1989-12-28 | Inst Kriobiologii I Kriomedits | Method for low-temperature preservation of embryos |
JPH02117601A (en) * | 1988-10-27 | 1990-05-02 | Itochu Shiryo Kk | Frozen fertilized ovum of pig and freezing preservation thereof |
Non-Patent Citations (2)
Title |
---|
PATENT ABSTRACTS OF JAPAN, C-510, page 163; & JP,A,63 035 501 (SNOW BRAND MILK PRODUCTS) 16 February 1988. * |
PATENT ABSTRACTS OF JAPAN, C-740, page 100; & JP,A,02 117 601 (ITOCHU SHIRYO K.K.) 2 May 1990. * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2306503A (en) * | 1995-10-30 | 1997-05-07 | Japanese Research Ass For Anim | A method of directly freezing porcine embryo |
US5707339A (en) * | 1995-10-30 | 1998-01-13 | The Japanese Research Association For Animal Embryo Transfer Technology | Method of directly freezing porcine embryos |
GB2306503B (en) * | 1995-10-30 | 1998-05-06 | Japanese Research Ass For Anim | A method of directly freezing porcine embryos |
NL1002209C2 (en) * | 1995-10-30 | 1999-03-29 | Japanese Research Ass For Anim | Method for freezing pig embryos directly. |
WO2000030441A1 (en) * | 1998-11-24 | 2000-06-02 | Bresagen Limited | Cryopreservation of oocytes and embryos and methods for producing animals involving the same |
AU2001268208B2 (en) * | 2000-06-06 | 2005-01-27 | The United States Of America As Represented By The Secretary Of Agriculture | Cryopreservation of swine embryos |
WO2001093676A1 (en) * | 2000-06-16 | 2001-12-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Cryopreservation of swine embryos |
US6503698B1 (en) * | 2000-06-16 | 2003-01-07 | The United States Of America As Represented By The Secretary Of Agriculture | Cryopreservation of swine embryos |
EP2331677A1 (en) * | 2008-08-29 | 2011-06-15 | The Curators Of The University Of Missouri | High-throughput and non-invasive method to vitrify porcine embryos |
EP2331677A4 (en) * | 2008-08-29 | 2013-07-24 | Univ Missouri | HIGH YIELD AND NON-VULNERANT METHOD OF VITRIFICATION OF PORK EMBRYOS |
US8852078B2 (en) | 2008-08-29 | 2014-10-07 | The Curators Of The University Of Missouri | High-throughput and non-invasive method to vitrify porcine embryos |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bos-Mikich et al. | Cytogenetical analysis and developmental potential of vitrified mouse oocytes | |
Rayos et al. | Quick freezing of unfertilized mouse oocytes using ethylene glycol with sucrose or trehalose | |
Diez et al. | Delipidating in vitro-produced bovine zygotes: effect on further development and consequences for freezability | |
Shaw et al. | An association between chromosomal abnormalities in rapidly frozen 2-cell mouse embryos and the ice-forming properties of the cryoprotective solution | |
Steel et al. | 120 Pregnancy rates resulting from transfer of fresh and frozen Holstein and Jersey embryos | |
WO1995005075A1 (en) | Cryopreservation of porcine embryos | |
US7138227B2 (en) | Frozen spermatozoa compositions and uses thereof | |
US20040161735A1 (en) | Cryopreservation of oocytes and embryos and methods for producing animals involving the same | |
Rayos et al. | Quick freezing of one-cell mouse embryos using ethylene glycol with sucrose | |
WO2000030441A1 (en) | Cryopreservation of oocytes and embryos and methods for producing animals involving the same | |
Lindemans et al. | 105 Vitrification of bovine embryos using the CLV method | |
Rall | Cryobiology of gametes and embryos from nonhuman primates | |
Kelly et al. | 102 vitrification of in vitro-produced bovine and ovine embryos using the minimum volume cooling Cryotop method | |
Kim et al. | 103 A new paper container for the vitrification of bovine embryos | |
Cremades et al. | 92 The addition of seminal plasma from individual boars to freezing extender can improve the post-thaw sperm survival | |
Nedambale | Evaluation of cryopreservation methods for in vitro produced bovine embryos | |
Chang et al. | 89 Effect of pre-equilibration procedures on the development potential of vitrified bovine oocytes after IVF | |
Kashiwazaki et al. | Freezing of in vivo derived and in vitro pre-cultured porcine blastocysts: differences of the cryoprotective effect between glycerol and ethylene glycol | |
Parnpai et al. | 116 Development into blastocysts of swamp buffalo oocytes after vitrification and nuclear transfer | |
Dinnyes et al. | 95 First report on cleavage development following cryopreservation of adult and prepubertal rhesus monkey (Macaca Mulatta) oocytes | |
Sagirkaya et al. | 118 Vitrification of pronuclear-stage mouse embryos on aluminum foil floating on liquid nitrogen | |
Niwa et al. | First cleavage of enucleated rat eggs following transplantation of karyoplast removed from pronuclear eggs stored at 2 to 6° C for various durations | |
Matoba et al. | 107 Toxicity of ethylene glycol on frozen and thawed IVP embryos in direct transfer method | |
Goda et al. | 97 Effect of rapid temperature change on viability of frozen-thawed IVM/IVF bovine embryos | |
Camargo et al. | 86 COMPARISON OF TWO VITRIFICATION PROTOCOLS FOR CROSSBREDBOS INDICUS× BOS TAURUS IN VITRO-PRODUCED EMBRYOS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KG KP KR KZ LK LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |